CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,776,331 | -13.8% | 127,260 | +8.3% | 0.01% | -25.0% |
Q2 2023 | $6,699,907 | +191819.4% | 117,501 | +48.7% | 0.01% | +33.3% |
Q1 2023 | $3,491 | -8.2% | 79,041 | -15.5% | 0.01% | +20.0% |
Q4 2022 | $3,802 | -99.9% | 93,526 | -5.0% | 0.01% | -50.0% |
Q3 2022 | $6,351,000 | -16.3% | 98,472 | -18.3% | 0.01% | -23.1% |
Q2 2022 | $7,592,000 | -16.1% | 120,512 | -14.7% | 0.01% | +8.3% |
Q1 2022 | $9,050,000 | -42.9% | 141,236 | -29.8% | 0.01% | -36.8% |
Q4 2021 | $15,855,000 | -23.5% | 201,086 | +6.9% | 0.02% | -17.4% |
Q3 2021 | $20,721,000 | -40.8% | 188,028 | -19.2% | 0.02% | -57.4% |
Q2 2021 | $35,020,000 | +26.3% | 232,702 | -3.3% | 0.05% | +25.6% |
Q1 2021 | $27,735,000 | +9.5% | 240,751 | +53.6% | 0.04% | +7.5% |
Q4 2020 | $25,325,000 | +302.5% | 156,747 | +111.7% | 0.04% | +166.7% |
Q3 2020 | $6,292,000 | -4.1% | 74,035 | -15.3% | 0.02% | -16.7% |
Q2 2020 | $6,564,000 | +122.0% | 87,456 | +31.0% | 0.02% | +100.0% |
Q1 2020 | $2,957,000 | -15.2% | 66,773 | +18.5% | 0.01% | +12.5% |
Q4 2019 | $3,485,000 | +36.6% | 56,357 | -6.4% | 0.01% | 0.0% |
Q3 2019 | $2,551,000 | -33.7% | 60,200 | -26.3% | 0.01% | -27.3% |
Q2 2019 | $3,848,000 | +67.5% | 81,700 | +27.1% | 0.01% | +83.3% |
Q1 2019 | $2,297,000 | +44.1% | 64,300 | +7.9% | 0.01% | +50.0% |
Q4 2018 | $1,594,000 | -40.0% | 59,600 | -0.5% | 0.00% | -33.3% |
Q3 2018 | $2,655,000 | – | 59,871 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |